Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pita and Cola--a devastating mixture?

Ohad Cohen

    The Israel Medical Association Journal : IMAJ
    |March 29, 2005
    PubMed
    Summary

    No abstract available in PubMed .

    Related Experiment Videos

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Impact of User Responses to Smart MDI Notifications: Insights From a Longitudinal Real-World Study of 2604 Smart MDI System Users.

    Diabetes, obesity & metabolism·2026
    Same author

    <i>Response to:</i> Quiros et al.: Baseline Glycemic Control and AID Efficacy in Type 1 Diabetes and Pregnancy.

    Diabetes technology & therapeutics·2026
    Same author

    Glycemic Concordance of Simplera Sync<b>™</b> and Instinct<b>™</b> Sensors in MiniMed<b>™</b> 780G System Users: A Randomized Crossover Feasibility Study.

    Diabetes technology & therapeutics·2026
    Same author

    Automated Insulin Delivery Maintains Stable Glycemic Control Across Seasons: Real-World Data From Italy on 4801 Users.

    Diabetes, obesity & metabolism·2026
    Same author

    Achieving Glycemic Targets in and out-of-School: Real-World Data From 1341 Italian Children Using the MiniMed 780G System During Auto Mode.

    Pediatric diabetes·2026
    Same author

    Real-World Performance of the MiniMed 780G Advanced Hybrid Closed-Loop System in the Middle East, North Africa, and Türkiye Region.

    Diabetes technology & therapeutics·2026